What Happened?
Florham Park, NJ-based Celularity Appointed Bradley Glover as Executive Vice President and Chief Technology Officer
About the Company
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity`s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature`s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases.
About the Person
Bradley Glover is Executive Vice President and Chief Operating Officer at Celularity. Previously, Bradley held various senior IT leadership roles in the industry.
Info Source
News
Short Profile